Acral vascular syndrome during an immune checkpoint inhibitor
Patrick O'Connor1, Pooja Bhadbhade2, Qamar Khan3
1University of Kansas School of Medicine, Kansas City, Kansas, USA poconnor2@kumc.edu.
Abstract:
Immune checkpoint inhibitors, including antiprogrammed death cell protein 1 (anti-PD-1) and anti cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4), have been associated with a range of autoimmune-related side effects since their introduction in cancer treatment. Small vessel digital necrosis, referred to as the acral vascular syndrome, is a rare but serious complication that can result in loss of digits. Here we present a case report of acral vascular syndrome and review possible aetiologies. A 45- year-old woman with invasive ductal carcinoma of the left breast presented to the emergency department during neoadjuvant treatment with carboplatin, docetaxel and pembrolizumab with complaints of severe pain in her right third digit. She had physical findings consistent with ischaemic necrosis and gangrene of the distal phalanx. Angiography demonstrated Raynaud's phenomenon in the distal portion of the digits. Laboratory testing showed a weakly positive RNA polymerase III antibody level. Her case resulted in surgical amputation of her affected digit after partial resolution of symptoms with prednisone, vasodilators and antibiotics.
Insights
Immune checkpoint inhibitors can cause rare autoimmune side effects like acral vascular syndrome, leading to digital necrosis. This case highlights a patient experiencing this rare complication during cancer treatment.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Immune checkpoint inhibitors (ICIs), such as anti-PD-1 and anti-CTLA-4, are crucial in cancer therapy.
- These therapies can induce various autoimmune-related adverse events.
- Acral vascular syndrome, a rare complication causing digital necrosis, has been linked to ICIs.
Observation:
- A 45-year-old woman with breast cancer developed severe digital pain during neoadjuvant therapy with pembrolizumab.
- Physical examination revealed ischemic necrosis and gangrene of the distal phalanx.
- Angiography showed Raynaud's phenomenon, and lab tests revealed a weakly positive RNA polymerase III antibody.
Findings:
- The patient presented with symptoms consistent with acral vascular syndrome.
- Treatment with prednisone, vasodilators, and antibiotics provided partial symptom relief.
- Surgical amputation of the affected digit was ultimately required.
Implications:
- This case underscores the potential for rare but severe autoimmune complications from ICIs.
- Early recognition and management of acral vascular syndrome are critical.
- Understanding the link between ICIs, autoimmune responses, and vascular complications is essential for patient care.
More Related Videos
Related Concept Videos
Vascular Spasm
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Peripheral Artery Disease IV: Nursing Management
Inflammatory Response I: Vascular and Cellular
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
